Amanote Research
Register
Sign In
The Design and Development of a Potent and Selective Novel Diprolyl Derivative That Binds to the NDomain of AngiotensinI Converting Enzyme
doi 10.1021/acs.jmedchem.7b01478.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Characterization of Domain-Selective Inhibitor Binding in Angiotensin-Converting Enzyme Using a Novel Derivative of Lisinopril
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Development of Domain-Selective Angiotensin I-Converting Enzyme Inhibitors
Annals of the New York Academy of Sciences
Genetics
Molecular Biology
Biochemistry
Neuroscience
History
Philosophy of Science
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Protective Effect of SM-19712, a Novel and Potent Endothelin Converting Enzyme Inhibitor, on Ischemic Acute Renal Failure in Rats.
The Japanese Journal of Pharmacology
A New Family of Rhamnogalacturonan Lyases Contains an Enzyme That Binds to Cellulose
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Structure-Based Design of Potent and Selective CK1γ Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Development of Potent and Selective Plasmodium Falciparum Calcium-Dependent Protein Kinase 4 (PfCDPK4) Inhibitors That Block the Transmission of Malaria to Mosquitoes
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Angiotensin-Converting Enzyme Inhibitors: Synthesis and Structure-Activity Relationships of Potent N-Benzyloxycarbonyl Tripeptide Inhibitors.
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease
Haematologica
Hematology
